Repositorio Dspace

Listar01.01. Investigación y comunicación científica por tema "SARS-CoV-2/immunology"

Listar01.01. Investigación y comunicación científica por tema "SARS-CoV-2/immunology"

Ordenar por:Orden:Resultados:

  • COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network 
    Delaunay, Charlotte-Laniece; Verdasca, Nuno; Monge, Susana; Domegan, Lisa; Seve, Noemie; Buda, Silke; Meijer, Adam; Lucaccioni, Heloise; López-Torrijos, Miriam; Mckenna, Adele; Enouf, Vincent; Duerrwald, Ralf; In't-Velt, Eline; de-Valcárcel-Laiglesia, Ma-Angel; Bennett, Charlene; Masse, Shirley; Erdwiens, Annika; Hooiveld, Mariette; Mlinaric, Ivan; Turi, Gergo; Rodrigues, Ana-Paula; Martínez-Baz, Iván; Lazar, Mihaela; Latorre-Margalef, Neus; Borges, Vitor; Kaczmarek, Marlena; Bacci, Sabrina; Kissling, Esther; European-Primary-Care-VE-Group (WILEY, 2025-05)
    We estimated the effectiveness of 2024/25 COVID-19 vaccination against medically attended SARS-CoV-2 infection in Europe, among target groups. We included 3204 patients (8/139 cases vaccinated: 6%; 517/3065 controls ...
  • COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans 
    Delaunay, Charlotte-Laniece; Mazagatos, Clara; Martínez-Baz, Ivan; Turi, Gergo; Goerlitz, Luise; Domegan, Lisa; Meijer, Adam; Rodrigues, Ana-Paula; Seve, Noemie; Ilic, Maja; Latorre-Margalef, Neus; Lazar, Mihaela; Maurel, Marine; Melo, Aryse; Andreu-Ivorra, Blanca; Casado, Itziar; Horvath, Judit-Krisztina; Buda, Silke; Bennett, Charlene; de-Lange, Marit; Guiomar, Raquel; Enouf, Vincent; Mlinaric, Ivan; Hagey, Tove-Samuelsson; Dinu, Sorin; Rumayor, Mercedes; Castilla, Jesús; Oroszi, Beatrix; Duerrwald, Ralf; O'Donnell, Joan; Hooiveld, Mariette; Gómez, Verónica; Falchi, Alessandra; Filipovic, Sanja-Kurecic; Dillner, Lena; Popescu, Rodica; Bacci, Sabrina; Kaczmarek, Marlena; Kissling, Esther (AMER MEDICAL ASSOC, 2024-07-01)
    IMPORTANCE: In the context of emerging SARS-CoV-2 variants or lineages and new vaccines, it is key to accurately monitor COVID-19 vaccine effectiveness (CVE) to inform vaccination campaigns. OBJECTIVE: To estimate the ...
  • Effectiveness of the autumnal COVID-19 vaccine dose during the winter and summer waves of the 2023/24 season in Spain 
    Rojas-Benedicto, Ayelen; Perez-Gimeno, Gloria; Mendioroz, Jacobo; Corral, Irene Pedrosa; Torrijos, Miriam Lopez; Rumayor, Mercedes; Lopez, Ma Angeles Rafael de la Cruz; Wagner, Eva Rivas; de Laiglesia, Ma Angel Valcarcel; Canete, Ines Guiu; Ibanez, Ana Fernandez; Martinez, Olaia Perez; Dopido, Juan Antonio Linares; Latasa, Pello; Torres-Juan, Marta; Recio, Ma Jesus Rodriguez; Castrillejo, Daniel; Raymundo, Luis Javier Viloria; Berrios, Ninoska Lopez; Vazquez-Moron, Sonia; Monge, Susana (TAYLOR & FRANCIS LTD, 2025-12-31)
    BACKGROUND: We estimated vaccine effectiveness (VE) of the COVID-19 monovalent XBB.1.5 vaccine recommended in Spain in October 2023 for ?60-year-olds against medically attended COVID-19 and COVID-19 hospitalization, during ...

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta